Follow
Matthew D Hall
Matthew D Hall
National Center for Advancing Translational Sciences (NCATS)
Verified email at mail.nih.gov - Homepage
Title
Cited by
Cited by
Year
Revisiting the role of ABC transporters in multidrug-resistant cancer
RW Robey, KM Pluchino, MD Hall, AT Fojo, SE Bates, MM Gottesman
Nature Reviews Cancer 18 (7), 452-464, 2018
9892018
Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes
DW Shen, LM Pouliot, MD Hall, MM Gottesman
Pharmacological reviews 64 (3), 706-721, 2012
8402012
Remdesivir: a review of its discovery and development leading to emergency use authorization for treatment of COVID-19
RT Eastman, JS Roth, KR Brimacombe, A Simeonov, M Shen, S Patnaik, ...
ACS central Science 6 (5), 672-683, 2020
6712020
Platinum (IV) antitumour compounds: their bioinorganic chemistry
MD Hall, TW Hambley
Coordination Chemistry Reviews 232 (1-2), 49-67, 2002
6652002
The discovery and development of cisplatin
RA Alderden, MD Hall, TW Hambley
Journal of chemical education 83 (5), 728, 2006
6162006
The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy
MD Hall, M Okabe, DW Shen, XJ Liang, MM Gottesman
Annual review of pharmacology and toxicology 48 (1), 495-535, 2008
5622008
Basis for design and development of platinum (IV) anticancer complexes
MD Hall, HR Mellor, R Callaghan, TW Hambley
Journal of medicinal chemistry 50 (15), 3403-3411, 2007
4602007
Collateral sensitivity as a strategy against cancer multidrug resistance
KM Pluchino, MD Hall, AS Goldsborough, R Callaghan, MM Gottesman
Drug Resistance Updates 15 (1-2), 98-105, 2012
3012012
Say No to DMSO: Dimethylsulfoxide Inactivates Cisplatin, Carboplatin, and Other Platinum ComplexesDMSO Inactivates Platinum Drugs
MD Hall, KA Telma, KE Chang, TD Lee, JP Madigan, JR Lloyd, ...
Cancer research 74 (14), 3913-3922, 2014
2902014
Effective transvascular delivery of nanoparticles across the blood-brain tumor barrier into malignant glioma cells
H Sarin, AS Kanevsky, H Wu, KR Brimacombe, SH Fung, AA Sousa, ...
Journal of translational medicine 6 (1), 1-15, 2008
2762008
Is resistance useless? Multidrug resistance and collateral sensitivity
MD Hall, MD Handley, MM Gottesman
Trends in pharmacological sciences 30 (10), 546-556, 2009
2752009
Toward a Better Understanding of the Complexity of Cancer Drug Resistance
MM Gottesman, O Lavi, MD Hall, JP Gillet
Pharmacology and Toxicology 56, 2016, 2015
2722015
Cisplatin is retained in the cochlea indefinitely following chemotherapy
AM Breglio, AE Rusheen, ED Shide, KA Fernandez, KK Spielbauer, ...
Nature communications 8 (1), 1-9, 2017
2232017
Imaging the function of P-glycoprotein with radiotracers: pharmacokinetics and in vivo applications
P Kannan, C John, SS Zoghbi, C Halldin, MM Gottesman, RB Innis, ...
Clinical Pharmacology & Therapeutics 86 (4), 368-377, 2009
2122009
Targeting the Achilles heel of multidrug-resistant cancer by exploiting the fitness cost of resistance
G Szakács, MD Hall, MM Gottesman, A Boumendjel, R Kachadourian, ...
Chemical reviews 114 (11), 5753-5774, 2014
1942014
Synthesis, activity, and pharmacophore development for isatin-β-thiosemicarbazones with selective activity toward multidrug-resistant cells
MD Hall, NK Salam, JL Hellawell, HM Fales, CB Kensler, JA Ludwig, ...
Journal of medicinal chemistry 52 (10), 3191-3204, 2009
1932009
Manganese Transport and Trafficking: Lessons Learned from Saccharomyces cerevisiae
VC Culotta, M Yang, MD Hall
Eukaryotic cell 4 (7), 1159-1165, 2005
1922005
The cellular distribution and oxidation state of platinum (II) and platinum (IV) antitumour complexes in cancer cells
MD Hall, CT Dillon, M Zhang, P Beale, Z Cai, B Lai, APJ Stampfl, ...
JBIC Journal of Biological Inorganic Chemistry 8 (7), 726-732, 2003
1822003
The “specific” P-glycoprotein inhibitor tariquidar is also a substrate and an inhibitor for breast cancer resistance protein (BCRP/ABCG2)
P Kannan, S Telu, S Shukla, SV Ambudkar, VW Pike, C Halldin, ...
ACS chemical neuroscience 2 (2), 82-89, 2011
1752011
Profiling SLCO and SLC22 genes in the NCI-60 cancer cell lines to identify drug uptake transporters
M Okabe, G Szakács, MA Reimers, T Suzuki, MD Hall, T Abe, ...
Molecular cancer therapeutics 7 (9), 3081-3091, 2008
1742008
The system can't perform the operation now. Try again later.
Articles 1–20